Role of Histology and Data in Selecting Optimal Therapy in nccRCC
Medical experts explore how non–clear cell RCC histology impacts treatment selection, addressing challenges with less common subtypes vs more frequent ones, and discuss how clinical data and experience inform treatment sequencing and shared decision-making.
Video content above is prompted by the following:
- How does the histology of nccRCC affect treatment selection?
What challenges are often faced when treating a patient with a less frequent subtype (collecting duct, renal medullary) vs.vs a more frequent subtype (papillary, chromophobe)?
- How do you utilize both clinical data and experience in your approach to treatment sequencing?
How do you facilitate shared discussion decision-making in treatment selection?
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
Related Content
